These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Autoimmune diseases and thalidomide. II. Adjuvant disease, experimental allergic encephalomyelitis and experimental allergic neuritis of the rat. Goihman-Yahr M, Requena MA, Vallecalle-Suegart E, Convit J. Int J Lepr Other Mycobact Dis; 1974 Apr; 42(3):266-75. PubMed ID: 4218599 [No Abstract] [Full Text] [Related]
3. Histochemical study of experimental allergic encephalitis. I. Data of neuropathology and lipid histochemistry. Dona G, Anghelescu N, Marcovici G, Petrescu A. Rev Roum Neurol; 1971 Apr; 8(4):307-13. PubMed ID: 5140350 [No Abstract] [Full Text] [Related]
4. Induction of recurrent experimental allergic encephalomyelitis with myelin basic protein. Panitch H, Ciccone C. Ann Neurol; 1981 May; 9(5):433-8. PubMed ID: 6168235 [Abstract] [Full Text] [Related]
5. A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis. Shaw CM, Alvord EC. Prog Clin Biol Res; 1984 May; 146():61-6. PubMed ID: 6201924 [No Abstract] [Full Text] [Related]
6. Acute demyelination in EAE after pretreatment with foreign protein and muramyl dipeptide (MDP). Colover J. Prog Clin Biol Res; 1984 May; 146():37-42. PubMed ID: 6718428 [No Abstract] [Full Text] [Related]
7. Delayed hypersensitivity to myelin basic protein in the passive transfer of experimental allergic encephalomyelitis. Falk GA, Kies MW, Alvord EC. J Immunol; 1968 Oct; 101(4):638-44. PubMed ID: 4971475 [No Abstract] [Full Text] [Related]
9. [Experimental allergic encephalomyelitis as model of a neuro-allergic disease]. Hitzschke B, Meyer-Rienecker H, Sayk J, Schröter P. Z Arztl Fortbild (Jena); 1969 Dec 15; 63(24):1315-20. PubMed ID: 5403442 [No Abstract] [Full Text] [Related]
10. Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant. Jagessar SA, Heijmans N, Blezer EL, Bauer J, Weissert R, 't Hart BA. J Neuroinflammation; 2015 Sep 17; 12():169. PubMed ID: 26377397 [Abstract] [Full Text] [Related]
11. Autoimmune diseases and thalidomide. I. Experimental allergic encephalomyelitis and experimental allergic neuritis of the guinea pig. Goihman-Yahr M, Requena MA, Vallecalle-Suegart E, Convit J. Int J Lepr Other Mycobact Dis; 1972 Sep 17; 40(2):133-41. PubMed ID: 4675051 [No Abstract] [Full Text] [Related]
12. Interconnection of demyelination processes and inflammation in the dynamics of experimental allergic encephalomyelitis. Khizhnyak MG, Zhitnukhin YL, Konovalov GV, Semenov SP. Acta Morphol Hung; 1988 Sep 17; 36(3-4):155-66. PubMed ID: 3151535 [Abstract] [Full Text] [Related]
16. Antigen-induced inhibition of experimental allergic encephalomyelitis. I. Inhibition in guinea pigs injected with non-encephalitogenic modified myelin basic protein. Swanborg RH. J Immunol; 1972 Sep 17; 109(3):540-6. PubMed ID: 4626655 [No Abstract] [Full Text] [Related]
17. Induction of experimental allergic encephalomyelitis in the goat. Purdy CW, Loan RW. Am J Vet Res; 1969 Jan 17; 30(1):85-9. PubMed ID: 5782569 [No Abstract] [Full Text] [Related]
18. Experimental autoimmune demyelination. Chronic relapsing models and their therapeutic implications for multiple sclerosis. Raine CS, Traugott U. Ann N Y Acad Sci; 1984 Jan 17; 436():33-51. PubMed ID: 6085228 [No Abstract] [Full Text] [Related]
19. Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction. Willenborg DO. J Immunol; 1979 Sep 17; 123(3):1145-50. PubMed ID: 313947 [No Abstract] [Full Text] [Related]